NEWS CENTER

/
/
<Traditional Chinese medicine treatment of chronic prostatitis clinical application guidelines> officially publish

<Traditional Chinese medicine treatment of chronic prostatitis clinical application guidelines> officially publish

  • Categories:News Center
  • Author:
  • Origin:
  • Time of issue:2022-05-26 15:21
  • Views:

<Traditional Chinese medicine treatment of chronic prostatitis clinical application guidelines> officially publish

  • Categories:News Center
  • Author:
  • Origin:
  • Time of issue:2022-05-26 15:21
  • Views:
Information

    According to People's Daily Online, the <clinical Application Guideline of Chinese Traditional Medicine in the Treatment of chronic prostatitis (2021)> was officially published in the latest issue of <Chinese Journal of Integrated Traditional and Western Medicine> on May 20. The guideline aims to standardize and promote the application of Traditional Chinese medicines in chronic prostatitis, improve the clinical efficacy of chronic prostatitis, and improve the quality of patients’ life.  

 

    Chronic prostatitis (CP) is a common and frequently occurring disease in male group, and there are many problems such as complex pathogenic factors, diversified clinical symptoms, controversial diagnostic methods and efficacy standards, and inconsistent duration of treatment course. Therefore, related researches on CP have been paid much attention to at home and abroad.

 

    Qianliexin capsule obtained the high recognition by traditional Chinese and western medicine experts. For the pain caused by chronic prostatitis (CP), the guide recommend Qianliexin capsule combining with western medicine to treat the patient, and clinical data also proved Qianliexin capsule very safe.

Qianliexin Capsule is an ideal effective drug for chronic prostatitis and prostate hyperplasia. It is the achievement of a six-year research by our company based on Prof. Liu Youfang's Qianliexian Decoction, a key research subject during China's Fifth Five-year Plan. Qianliexin Capsule has passed the Medical Ministry New Drug Examination & Evaluation and gained State Certificate of New Drug in 1995. It has started to be offered on market in 1996. Years of clinical observation have showed that Qianliexin Capsule has remarkable therapeutic effects, with the curative ratio up to 72.6% and the effective rate of 98.9%.

 

[Ingredients] Semen Persicae, Myrrha, Radix Salviae Miltiorrhizae, Radix Paeoniae Rubra, Flos Carthami, Herbalycopi etc.

[Action] To activate blood, resolve stasis, clear heat and drain damp.

[Indications] For treating stagnant blood, improving the symptom of Chronic prostatitis and prostate hypertrophy due to the damp-heat pouring downward, namely frequent micturition, urination pain and difficulty.

[Package] 54 capsules/box.

[Usage and Dosage] Take orally. 4~6 capsules a time, 3 times a day, or following the doctor’s advice.

Remarks: 9 boxes is a course of treatment.

Scan the QR code to read on your phone

1
1

ADD

No.30766,East Jingshi Road,Jinan City,shandong Province,China,250103

1

E-mail

sales@hjt.cn

1

ADD

30766 jingshidong Road, Jinan, Shandong, China

代码

代码

Time of issue:2020-03-29 00:00:00

Copyright © HONGJITANG All Rights Reserved ICP16043600 POWERED BY WWW.300.CN